Arcutis Biotherapeutics Inc (ARQT)
9.93
-0.54
(-5.16%)
USD |
NASDAQ |
Nov 14, 16:00
9.93
0.00 (0.00%)
Pre-Market: 08:51
Arcutis Biotherapeutics Cash from Operations (Quarterly): -34.69M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -34.69M |
| June 30, 2024 | -45.12M |
| March 31, 2024 | -31.60M |
| December 31, 2023 | -56.24M |
| September 30, 2023 | -43.98M |
| June 30, 2023 | -66.48M |
| March 31, 2023 | -80.34M |
| December 31, 2022 | -71.06M |
| September 30, 2022 | -67.70M |
| June 30, 2022 | -61.98M |
| March 31, 2022 | -56.98M |
| December 31, 2021 | -51.71M |
| Date | Value |
|---|---|
| September 30, 2021 | -40.88M |
| June 30, 2021 | -35.83M |
| March 31, 2021 | -46.20M |
| December 31, 2020 | -32.57M |
| September 30, 2020 | -33.69M |
| June 30, 2020 | -25.76M |
| March 31, 2020 | -21.01M |
| December 31, 2019 | -16.80M |
| September 30, 2019 | -10.72M |
| June 30, 2019 | -8.243M |
| March 31, 2019 | -7.074M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-80.34M
Minimum
Mar 2023
-16.80M
Maximum
Dec 2019
-46.03M
Average
-44.55M
Median
Cash from Operations (Quarterly) Benchmarks
| Mirum Pharmaceuticals Inc | -3.803M |
| Biogen Inc | 935.60M |
| Vertex Pharmaceuticals Inc | 1.370B |
| NovaBay Pharmaceuticals Inc | -2.061M |
| Palatin Technologies Inc | -6.472M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 84.78M |
| Cash from Financing (Quarterly) | 0.394M |
| Free Cash Flow | -167.80M |
| Free Cash Flow Per Share (Quarterly) | -0.2802 |
| Free Cash Flow to Equity (Quarterly) | -35.63M |
| Free Cash Flow to Firm (Quarterly) | -28.18M |
| Free Cash Flow Yield | -14.84% |